Shagun Singh
Stock Analyst at RBC Capital
(3.43)
# 965
Out of 5,113 analysts
245
Total ratings
51.69%
Success rate
3.22%
Average return
Main Sectors:
Stocks Rated by Shagun Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Maintains: Outperform | $147 → $135 | $108.77 | +24.12% | 18 | Jan 23, 2026 | |
| PEN Penumbra | Downgrades: Sector Perform | $355 → $374 | $359.00 | +4.18% | 16 | Jan 20, 2026 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $625 → $650 | $528.81 | +22.92% | 18 | Dec 17, 2025 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $125 → $175 | $81.33 | +115.17% | 8 | Dec 17, 2025 | |
| GMED Globus Medical | Maintains: Outperform | $92 → $100 | $92.98 | +7.55% | 9 | Dec 17, 2025 | |
| BSX Boston Scientific | Maintains: Outperform | $125 → $130 | $93.55 | +38.96% | 18 | Dec 17, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Sector Perform | $202 → $210 | $203.42 | +3.23% | 4 | Dec 17, 2025 | |
| JNJ Johnson & Johnson | Maintains: Outperform | $209 → $230 | $221.49 | +3.84% | 23 | Dec 11, 2025 | |
| EW Edwards Lifesciences | Maintains: Outperform | $95 → $100 | $84.27 | +18.67% | 24 | Dec 5, 2025 | |
| PODD Insulet | Maintains: Outperform | $370 → $380 | $271.31 | +40.06% | 4 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $111 → $118 | $100.67 | +17.21% | 22 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $22 → $17 | $4.97 | +242.05% | 14 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $135 → $120 | $104.20 | +15.16% | 23 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $111 → $101 | $87.32 | +15.67% | 17 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $85 | $73.34 | +15.90% | 5 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $45 → $25 | $20.20 | +23.76% | 3 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $425 → $435 | $356.98 | +21.86% | 19 | Jan 29, 2025 |
Abbott Laboratories
Jan 23, 2026
Maintains: Outperform
Price Target: $147 → $135
Current: $108.77
Upside: +24.12%
Penumbra
Jan 20, 2026
Downgrades: Sector Perform
Price Target: $355 → $374
Current: $359.00
Upside: +4.18%
Intuitive Surgical
Dec 17, 2025
Maintains: Outperform
Price Target: $625 → $650
Current: $528.81
Upside: +22.92%
Inspire Medical Systems
Dec 17, 2025
Maintains: Outperform
Price Target: $125 → $175
Current: $81.33
Upside: +115.17%
Globus Medical
Dec 17, 2025
Maintains: Outperform
Price Target: $92 → $100
Current: $92.98
Upside: +7.55%
Boston Scientific
Dec 17, 2025
Maintains: Outperform
Price Target: $125 → $130
Current: $93.55
Upside: +38.96%
Becton, Dickinson and Company
Dec 17, 2025
Maintains: Sector Perform
Price Target: $202 → $210
Current: $203.42
Upside: +3.23%
Johnson & Johnson
Dec 11, 2025
Maintains: Outperform
Price Target: $209 → $230
Current: $221.49
Upside: +3.84%
Edwards Lifesciences
Dec 5, 2025
Maintains: Outperform
Price Target: $95 → $100
Current: $84.27
Upside: +18.67%
Insulet
Nov 21, 2025
Maintains: Outperform
Price Target: $370 → $380
Current: $271.31
Upside: +40.06%
Nov 19, 2025
Maintains: Outperform
Price Target: $111 → $118
Current: $100.67
Upside: +17.21%
Nov 11, 2025
Maintains: Sector Perform
Price Target: $22 → $17
Current: $4.97
Upside: +242.05%
Nov 7, 2025
Maintains: Sector Perform
Price Target: $135 → $120
Current: $104.20
Upside: +15.16%
Nov 6, 2025
Maintains: Outperform
Price Target: $111 → $101
Current: $87.32
Upside: +15.67%
Oct 31, 2025
Maintains: Outperform
Price Target: $100 → $85
Current: $73.34
Upside: +15.90%
Aug 7, 2025
Maintains: Outperform
Price Target: $45 → $25
Current: $20.20
Upside: +23.76%
Jan 29, 2025
Maintains: Outperform
Price Target: $425 → $435
Current: $356.98
Upside: +21.86%